CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MANUS Neurodynamica is developing a system to detect early signs of Parkinson's disease through advanced neuromuscular analysis. The project aims to enhance diagnosis and care planning, ultimately improving the quality of life for patients affected by this degenerative condition.
MANUS Neurodynamica, a high-tech startup based in the North East of England has developed a novel system to detect and characterize the earliest changes in the neuromuscular system associated with the onset of Parkinson’s disease.
This illness, which affects 5 citizens in every 1000 over the age of 60, is chronic, degenerative and currently incurable.
Although there are promising therapies on the horizon, the best patient outcome available today can only be delivered on basis of early and accura…
Hispafuentes S.L.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, MARKKLEEBERG
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Germany, BORSDORF
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, DORNOCH
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
